Measurement uncertainty, reference change value, and total error of total and free prostate specific antigen tests
Open Access
- 14 July 2026
- journal article
- Published by Walter de Gruyter GmbH in Turkish Journal of Biochemistry
Abstract
Objectives: The dispersion of measurement results is defined as the measurement uncertainty (MU), and the reference change value (RCV) indicates whether the difference between the current result and previous results is significant. The purpose of this study is to evaluate whether the analytical performance of total PSA (tPSA) and free PSA (fPSA) measurements conforms to international quality standards by determining analytical coefficient of variation (CVA), Bias, MU, and RCV values and comparing them with European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)’s allowable limits. Methods: The study includes Internal Quality Control (IQC) and External Quality Assurance (EQA) results for the period from August 2021 to February 2022 of tPSA and fPSA. While the long-term CV was obtained from IQC for MU and RCV values, Total Error (TE) values were calculated with the monthly IQC CV and EQA bias. MU Extended values (MU%) are calculated according to ISO/TS 20914. Results: The CVA of tPSA and fPSA was 3.44 % and 7.26 %, respectively. tPSA’s RCV and MU were found to be 17.78 and 9.74, and fPSA’s RCV and MU were found to be 23.7 and 15.23, respectively. Conclusions: Our results indicate that tPSA demonstrates better analytical performance than fPSA due to its lower CV and bias values. We found that the RCV of a test, such as tPSA and fPSA, which play a key role in post-operative follow-up, must be calculated and shared with the surgeon. In addition, since the cut-off value decides whether or not to request a reflective fPSA, MU should also be calculated and reported.Keywords
This publication has 10 references indexed in Scilit:
- Serum Prostate-Specific Antigen Testing for Early Detection of Prostate Cancer: Managing the Gap between Clinical and Laboratory PracticeClinical Chemistry, 2021
- Can post‐treatment free PSA ratio be used to predict adverse outcomes in recurrent prostate cancer?BJU International, 2020
- Prognostic significance of a novel indicator (PSApostd3/PSApre) for PSA recurrence in patients after radical prostatectomyCancer Management and Research, 2019
- Biochemical recurrence after radical prostatectomy: what does it mean?International braz j urol, 2018
- Useful measures and models for analytical quality management in medical laboratoriesClinical Chemistry and Laboratory Medicine (CCLM), 2016
- Permissible limits for uncertainty of measurement in laboratory medicineClinical Chemistry and Laboratory Medicine (CCLM), 2015
- Reference change valuesClinical Chemistry and Laboratory Medicine (CCLM), 2011
- Different prostate‐specific antigen assays give different results on the same blood sample: an obstacle to recommending uniform limits for prostate biopsiesBJU International, 2007
- Generation and Application of Data on Biological Variation in Clinical ChemistryCritical Reviews in Clinical Laboratory Sciences, 1989
- On the calculation of a "reference change" for comparing two consecutive measurements.Clinical Chemistry, 1983